Understanding Investor Psychology
Investing, whether it be in stocks, cryptocurrency, bonds, or anything else, is very quickly becoming one of the most effective…
Thermo Fisher (NYSE:TMO): A classic blue-chip health stock for the rest of the 2020s
Capped at over US$180bn, Thermo Fisher (NYSE:TMO) is a classic blue-chip healthcare stock. It has not escaped an impact from…
Game developer stocks and their investor appeal
Games now out-earn film and recorded music, and the business looks more like software than box-office. Digital distribution cuts costs;…
Core Lithium (ASX: CXO) Up 80% This Month — Is It Time to Buy, Sell or Hold?
Core Lithium (ASX: CXO) surged to a 52-week high of $0.22 today, capping an 80% rally over the past month.…
Excelsior Capital (ASX: ECL) Liquidation Vote: Sell or Hold?
Excelsior Capital (ASX: ECL) faces its most dramatic shareholder meeting in years today, with investors voting on whether to liquidate…
TechnologyOne shares drop 18%, but the market may be missing the real story
TechnologyOne shares slide 18 percent, but the cash flow strength tells a very different story TechnologyOne (ASX:TNE) shares fell on…
The Trust Economy Is Taking Over Online Markets
People rely on digital services more than ever, and that shift highlights how much trust shapes every online decision. Users…
Dateline Drops 8% Despite Strong Colosseum Gold Assays as Small Caps Face Market Rotation
Dateline Shares Slip on Sentiment as New Colosseum Drill Results Strengthen Feasibility Pathway Dateline Resources (ASX: DTR) saw an interesting…
TMK Energy Rockets 30 Percent as Gurvantes Gas Output Hits Record Levels
TMK Energy Jumps on Market as Gurvantes Production Beats 2025 Targets with Record Flows TMK Energy (ASX: TMK) surged 30%…
AML3D Surges After Landing 9th US Order with A$1.7m ARCEMY X Deal
AML3D Extends US Momentum, Stock Rises on Major A$1.69m ARCEMY X Sale to FasTech AML3D (ASX: AL3) continues to build…
Prescient Therapeutics (ASX:PTX): It has taken the plunge into a Phase 2 trial against T-Cell Lymphoma
There’s plenty of ASX oncology biotechs conducting clinical trials, but Prescient Therapeutics (ASX:PTX) is one of the closest to commercialisation.…
Here Are 5 Times Activist Short Sellers Brought Down a Company; And 5 Times They Failed
Last week’s attack on IperionX (ASX:IPX) by Activist Short Sellers was not the first time this has happened, but we…